|
| |
eIF2B-delta
| Symbol: | eIF2B-delta | | Name(s): | eIF2B-delta | | Type: | protein-coding | | Organism: | Drosophila melanogaster | | Synonyms: | CG10315, eIF2Bdelta | | Links: |
Pubmed,
Entrez Gene,
Map Viewer.
|
Press Releases on eIF2B-delta:
|
 |
| Sangamo BioSciences Research Collaborators Awarded Grant From California Institute for Regenerative Medicine to Develop Zinc Finger Nuclease-Based Stem Cell Therapy for HIV/AIDS |
28th October, 2009 |
Sangamo BioSciences, Inc. |
RICHMOND, Calif. Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the California Institute for Regenerative Medicine (CIRM) has
|
| China Nepstar Enters Wenzhou Market with Acquisition |
23rd October, 2009 |
China Nepstar Chain Drugstore Ltd. |
SHENZHEN, China, Oct. 23 /PRNewswire-Asia-FirstCall/ -- China Nepstar
Chain Drugstore Ltd. (NYSE: NPD) ("China Nepstar" or the "Company"), the
largest drugstore chain in
|
| Delta to Turn JFK Tower Pink, Host In-Flight Jam Session |
28th September, 2009 |
Delta Air Lines |
ATLANTA, Sept. 28 /PRNewswire-FirstCall/ -- Delta Air Lines (NYSE: DAL) will kick off its fifth year of support for The Breast Cancer Research Foundation (BCRF) Sept. 29 by
|
| Intellikine Completes $51 Million Financing |
8th July, 2009 |
Intellikine, Inc. |
LA JOLLA, Calif., July 8 /PRNewswire/ -- Intellikine, Inc., a leader in the development of innovative, small molecule drugs for the treatment of cancer, inflammation and autoimmune diseases,
|
| Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 |
8th June, 2009 |
Sangamo |
Analysis of Subjects with Moderately Severe Diabetic Neuropathy Shows Statistically Significant Improvement in Multiple Quantitative Neurological Endpoints
RICHMOND, <
|
eIF2B-delta results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for eIF2B-delta,
or search for eIF2B-delta on BioPortfolio's antibody search engine.
This page has been viewed 69 times
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
